New-Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine-Induced Thrombotic Thrombocytopenia
LIVER TRANSPLANTATION(2022)
Abstract
Since February 2021, some recipients of ChAdOx1 nCov-19 or Ad26.COV2.S vaccines have been observed to have developed antibodies against platelet factor-4 (PF4)/polyanion complexes, thrombocytopenia and thrombosis, a severe condition resembling Heparin-Induced Thrombocytopenia (HIT) (1). The syndrome has been termed "Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)" or "Thrombosis with Thrombocytopenia Syndrome (TTS)" (6).
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined